Arndt Weinmann

7.8k total citations
161 papers, 3.3k citations indexed

About

Arndt Weinmann is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Arndt Weinmann has authored 161 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hepatology, 53 papers in Epidemiology and 45 papers in Oncology. Recurrent topics in Arndt Weinmann's work include Hepatocellular Carcinoma Treatment and Prognosis (69 papers), Liver Disease Diagnosis and Treatment (41 papers) and Liver Disease and Transplantation (31 papers). Arndt Weinmann is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (69 papers), Liver Disease Diagnosis and Treatment (41 papers) and Liver Disease and Transplantation (31 papers). Arndt Weinmann collaborates with scholars based in Germany, United States and Austria. Arndt Weinmann's co-authors include Peter R. Galle, Marcus Schuchmann, Marcus A. Wörns, Gerd Otto, Christoph Düber, Roman Kloeckner, Michael B. Pitton, Andreas Teufel, Sandra Koch and Martin F. Sprinzl and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Arndt Weinmann

159 papers receiving 3.2k citations

Peers

Countries citing papers authored by Arndt Weinmann

Since Specialization

Citations

This map shows the geographic impact of Arndt Weinmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arndt Weinmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arndt Weinmann more than expected).

Fields of papers citing papers by Arndt Weinmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arndt Weinmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arndt Weinmann. The network helps show where Arndt Weinmann may publish in the future.

Co-authorship network of co-authors of Arndt Weinmann

This figure shows the co-authorship network connecting the top 25 collaborators of Arndt Weinmann. A scholar is included among the top collaborators of Arndt Weinmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arndt Weinmann. Arndt Weinmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vascular resection and reconstruction in surgery for advanced intrahepatic cholangiocarcinoma – single center experience with 59 vascular resections 2025 ·European Journal of Surgical Oncology ·Hauke Lang, (unknown), Beate K. Straub, Tobias Huber, (unknown), Catherine Scholz, Friedrich Foerster, Arndt Weinmann, Katja Oberholzer, J. Baumgart, Jens Mittler, F. Bartsch	0
2	Evaluation of four chatbots in autoimmune liver disease: A comparative analysis 2024 ·Annals of Hepatology ·(unknown), (unknown), (unknown), (unknown), Heike Bantel, Marcos Girala, Matthias P. Ebert, Florian van Bömmel, Andreas Geier, Andrés Gómez-Aldana, Kevin Yau, Mário Reis Álvares‐da‐Silva, (unknown), Ezequiel Ridruejo, Arndt Weinmann, Andreas Teufel	6
3	Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates 2023 ·Cancer Imaging ·Lukáš Müller, Simon Johannes Gairing, Friedrich Foerster, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Dirk Graafen, Christoph Düber, Peter R. Galle, Roman Kloeckner, Felix Hähn	2
4	Plasma exchange for treatment of a therapy‐related thrombotic microangiopathy in a patient with advanced hepatocellular carcinoma—A case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), Kateryna Shmanko, Daniel Kraus, Simon Johannes Gairing, Simone Cosima Boedecker-Lips, (unknown), Arndt Weinmann, Julia Weinmann‐Menke	2
5	Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center 2023 ·Cancers ·(unknown), (unknown), Maria Hoppe‐Lotichius, J. Baumgart, Stefan Heinrich, Jens Mittler, (unknown), Beate K. Straub, Arndt Weinmann, F. Bartsch, Hauke Lang	2
6	Reduced Lipid Peroxidation Predicts Unfavorable Prognosis in Hepatocellular Carcinoma, but Not Intrahepatic Cholangiocarcinoma 2023 ·Biomedicines ·(unknown), Hagen Roland Witzel, Arndt Weinmann, F. Bartsch, Mario Schindeldecker, Peter R. Galle, Hauke Lang, Wilfried Roth, Dirk A. Ridder, Beate K. Straub	2
7	Elderly Patients with Hepatocellular Carcinoma Benefit from Liver Transplantation as Much as Younger Ones 2022 ·Liver Cancer ·Jens Mittler, Stefan Heinrich, Martina Koch, Maria Hoppe‐Lotichius, (unknown), Arndt Weinmann, Roman Kloeckner, Peter R. Galle, Hauke Lang	4
8	Bevacizumab in combination with octreotide rescues a patient with liver cirrhosis, GAVE syndrome and refractory hemorrhage – a case report 2022 ·Zeitschrift für Gastroenterologie ·Simon Johannes Gairing, (unknown), Lukáš Müller, Christian Labenz, (unknown), Daniela Grimm, Visvakanth Sivanathan, Arndt Weinmann, (unknown), Roman Kloeckner, Michael B. Pitton, Florian M. Thieringer, (unknown), Peter R. Galle, Jörn M. Schattenberg, Friedrich Foerster	2
9	Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization 2021 ·United European Gastroenterology Journal ·Lukáš Müller, Felix Hähn, Aline Mähringer‐Kunz, Fabian Stoehr, Simon Johannes Gairing, Friedrich Foerster, Arndt Weinmann, Peter R. Galle, Jens Mittler, Daniel Pinto dos Santos, Michael B. Pitton, Christoph Düber, Uli Fehrenbach, Timo Alexander Auer, Bernhard Gebauer, Roman Kloeckner	14
10	Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week 2021 ·CardioVascular and Interventional Radiology ·Michael B. Pitton, Arndt Weinmann, Roman Kloeckner, Jens Mittler, Christian Ruckes, Christoph Düber, Gerd Otto	7
11	PD-8 Regorafenib with TAS-102 in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY) 2020 ·Annals of Oncology ·Markus Moehler, Alexander Stein, Jörg Trojan, Jens U. Marquardt, Julia Quidde, Oliver Waidmann, Arndt Weinmann, (unknown), (unknown), Markus G. Manz, (unknown)	1
12	Fatigue in SLE: diagnostic and pathogenic impact of anti-N-methyl-D-aspartate receptor (NMDAR) autoantibodies 2019 ·Annals of the Rheumatic Diseases ·Andreas Schwarting, (unknown), (unknown), Konstantinos Triantafyllias, (unknown), Simone Cosima Boedecker-Lips, Arndt Weinmann, Myriam Meineck, Clemens Sommer, Ingrid Schermuly, Andreas Fellgiebel, Felix Luessi, Julia Weinmann‐Menke	21
13	Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma 2019 ·Liver International ·(unknown), Bernhard Scheiner, Torsten Voigtländer, Sandra Koch, Nóra Schweitzer, Silke Marhenke, Philipp Ivanyi, Michael P. Manns, Thomas Rodt, Jan B. Hinrichs, Arndt Weinmann, Matthias Pinter, Arndt Vogel, Martha M. Kirstein	48
14	Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular Carcinoma 2018 ·Liver Cancer ·Martin F. Sprinzl, Martha M. Kirstein, Sandra Koch, (unknown), Julia Weinmann‐Menke, Hauke Lang, Christoph Düber, Gerrit Toenges, Daniela Zöller, Jens U. Marquardt, Marcus‐Alexander Wörns, Peter R. Galle, Arndt Vogel, Matthias Pinter, Arndt Weinmann	19
15	Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib 2017 ·Digestive Diseases ·Christian Labenz, (unknown), Sandra Koch, Yvonne Huber, Jens U. Marquardt, Jörn M. Schattenberg, Peter R. Galle, Arndt Weinmann, Marcus‐Alexander Wörns	7
16	Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease 2017 ·United European Gastroenterology Journal ·Martha M. Kirstein, Torsten Voigtländer, Nóra Schweitzer, Jan B. Hinrichs, Jens U. Marquardt, Marcus‐Alexander Wörns, Roman Kloeckner, Thorben Fründt, Harald Ittrich, Frank Wacker, Thomas Rodt, Michael P. Manns, Henning Wege, Arndt Weinmann, Arndt Vogel	16
17	Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma 2015 ·BMC Cancer ·Roman Kloeckner, Arndt Weinmann, Friederike Prinz, Daniel Pinto dos Santos, Christian Ruckes, Christoph Dueber, Michael B. Pitton	99
18	Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma – A single-center experience 2013 ·European Journal of Surgical Oncology ·Uwe Scheuermann, J. Moritz Kaths, Michael Heise, Michael B. Pitton, Arndt Weinmann, Maria Hoppe‐Lotichius, G. Otto	45
19	Das Interdisziplinäre Hepatologische Zentrum Mainz 2006 ·Visceral Medicine ·Gerd Otto, Marcus Schuchmann, J Thies, Arndt Weinmann, Christian Mönch, Peter R. Galle	1
20	HoxC8 in cancer: Suppressor or progressor? 2005 ·Cancer Research ·Carl Christoph Schimanski, (unknown), (unknown), Arndt Weinmann, Martin R. Berger, Peter R. Galle, Susanne Strand, Dennis Strand	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact